Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Urothelial Cancer 1

Interventions

Carboplatin 11 pembrolizumab 10 Gemcitabine 8 Cisplatin 8 Rituximab 7 osimertinib 5 durvalumab 5 Specimen Handling 5 Pemetrexed 5 Nivolumab 5 Dexamethasone 5 belzutifan 4 atezolizumab 4 amivantamab 4 Prednisone 4 Paclitaxel 4 Cyclophosphamide 4 Bortezomib 4 trastuzumab deruxtecan 3 olaparib 3 lazertinib 3 entrectinib 3 enfortumab vedotin 3 daratumumab 3 alectinib 3 acalabrutinib 3 X-Rays 3 Vinorelbine 3 Oxaliplatin 3 Midazolam 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × avelumab × 90 days × Clear all

NCT03547973 2026-03-16

TROPHY U-01

Gilead Sciences

Phase 2 Recruiting

827 enrolled 1 FDA

Metastatic Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡